TABLE 2.
Anthropometrics and fasting plasma lipid concentrations of healthy young male and female adults at days 0 and 28 of ALA and DHA supplementation1
| ALA supplementation | DHA supplementation | |||||||
|---|---|---|---|---|---|---|---|---|
| Day 0 | Day 28 | Day 0 | Day 28 | |||||
| Male | Female | Male | Female | Male | Female | Male | Female | |
| Body weight, kg | 77.3 ± 6.0 | 70.4 ± 2.8 | 76.6 ± 6.0 | 70.4 ± 2.5 | 76.5 ± 6.3 | 69.4 ± 2.3 | 76.9 ± 7.4 | 70.4 ± 2.6 |
| BMI, kg/m2 | 23.6 ± 1.1 | 25.5 ± 0.7 | 24.0 ± 1.2 | 25.9 ± 0.8 | 23.8 ± 1.1 | 25.9 ± 0.7 | 23.6 ± 1.1 | 25.8 ± 0.7 |
| Systolic BP, mmHg | 118 ± 2.8 | 114 ± 4.4 | 118 ± 3.5 | 112 ± 5.3 | 119 ± 2.6 | 119 ± 4.4 | 117 ± 6.6 | 113 ± 4.6 |
| Diastolic BP, mmHg | 77 ± 2.0 | 76 ± 2.8 | 74 ± 3.4 | 74 ± 3.1 | 75 ± 1.2 | 79 ± 2.6 | 74 ± 2.8 | 76 ± 2.7 |
| TC, mmol/L | 4.2 ± 0.1 | 4.7 ± 0.3 | 4.5 ± 0.2 | 4.5 ± 0.4 | 4.3 ± 0.1 | 4.4 ± 0.3 | 4.6 ± 0.3 | 4.4 ± 0.2 |
| TAG, mmol/L | 0.8 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.3 | 0.7 ± 0.0 | 1.0 ± 0.3 | 1.0 ± 0.2 | 1.0 ± 0.1 | 1.0 ± 0.2 |
| HDL-C,2 mmol/L | 1.4 ± 0.1 | 2.1 ± 0.3 | 1.4 ± 0.1 | 2.3 ± 0.4 | 1.3 ± 0.1 | 2.1 ± 0.3 | 1.4 ± 0.1 | 2.1 ± 0.4 |
| LDL-C,2 mmol/L | 2.4 ± 0.2 | 2.2 ± 0.2 | 2.7 ± 0.2 | 2.0 ± 0.1 | 2.6 ± 0.2 | 1.9 ± 0.2 | 2.7 ± 0.3 | 1.8 ± 0.2 |
| C/HDL-C2 | 3.3 ± 0.3 | 2.4 ± 0.2 | 3.4 ± 0.3 | 2.2 ± 0.3 | 3.5 ± 0.3 | 2.3 ± 0.2 | 3.3 ± 0.3 | 2.4 ± 0.3 |
| LDL-C/HDL-C2 | 1.9 ± 0.2 | 1.2 ± 0.2 | 2.1 ± 0.3 | 1.1 ± 0.2 | 2.1 ± 0.3 | 1.1 ± 0.2 | 2.0 ± 0.3 | 1.1 ± 0.3 |
1
Data were analyzed using a mixed model with individuals as a random effect, and time, supplementation, and sex as fixed effects. No supplementation or time effects were significant. Values reported as mean ± SEM; n = 6 for each group, except n = 5 for male day 28 time point in the DHA supplementation phase. ALA, α-linolenic acid; BP, blood pressure; C, cholesterol; TAG, triacylglycerols; TC, total cholesterol, .
2
Overall sex effect.